| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 03/12/2002 | US6355483 Antisense nucleotides for use in the treatment of leukemia |
| 03/12/2002 | US6355479 Insect polypeptide for use in the treatment of autoimmune diseases, allergies and cancer |
| 03/12/2002 | US6355463 UDP-N-acetylenolpyruvylglucosamine reductase |
| 03/12/2002 | US6355460 Detecting enzyme inhibitors; incubate enzyme with modulator, monitor sample for reduction in enzyme activity, reduction in enzyme activity indicates modulator |
| 03/12/2002 | US6355451 Low density lipoprotein binding proteins and their use in diagnosing and treating atherosclerosis |
| 03/12/2002 | US6355446 DocosahexAenoic acid as retinoid X-receptor ligand and uses thereof |
| 03/12/2002 | US6355418 Chimeric oligonucleotides and uses thereof in the identification of antisense binding sites |
| 03/12/2002 | US6355274 Encapsulated long chain alcohols |
| 03/12/2002 | US6355270 Particles for oral delivery of peptides and proteins |
| 03/12/2002 | US6355269 Oral compositions of levosimendan |
| 03/12/2002 | US6355268 Liposome-entrapped topoisomerase inhibitors |
| 03/12/2002 | US6355266 Indomethacin-containing patch; for theray of pain due to contusion, sprain or muscular fatigue, and pain associated with shoulder stiffness |
| 03/12/2002 | US6355261 Ultraviolet radiation absorbing waxes useful in cosmetic compositions |
| 03/12/2002 | US6355259 Cosmetic composition for skin comprising urea |
| 03/12/2002 | US6355258 Method for formulating spill resistant pharmaceutical compositions in semi-solid form |
| 03/12/2002 | US6355257 Aminoalkyl glucosamine phosphate compounds and their use as adjuvants and immunoeffectors |
| 03/12/2002 | US6355254 Pathogenic Escherichia coli associated protein EspA |
| 03/12/2002 | US6355251 Compositions and methods for epidermal chemexfoliation |
| 03/12/2002 | US6355241 In vivo production and delivery of erythropoietin |
| 03/12/2002 | CA2347330C Liquid injectable formulation of disodium pamidronate |
| 03/12/2002 | CA2313783C Pharmaceutical compositions of (e)-7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl]-(3r,5s)-3,5-dihydroxyhept-6-enoic acid or a salt thereof |
| 03/12/2002 | CA2235625C Bactericidal/permeability increasing protein (bpi) for treating conditions associated with corneal transplantation |
| 03/12/2002 | CA2200773C Process for reducing light-induced blueing in cosmetic compounds containing titanium oxide pigments and in compounds and applications |
| 03/12/2002 | CA2187214C Aminostilbazole derivative and medicine |
| 03/12/2002 | CA2137889C Eburnan analogs; process for preparing the same and pharmaceutical compositions containing them |
| 03/12/2002 | CA2099262C (-)-[[4-(1,4,5,6-tetrahydro-4-methyl-6-oxo-3-pyridazinyl) phenyl]hydrazono]propanedinitrile |
| 03/12/2002 | CA2086438C Anti-herpes virus and cytomegalovirus oligomers |
| 03/12/2002 | CA2060393C Carbamic acid derivatives and method for preparing the same |
| 03/12/2002 | CA2055947C Condensed heterocyclic compounds, their production and use |
| 03/12/2002 | CA2053527C Pyridine derivatives, their production and use |
| 03/12/2002 | CA2047944C Process for preparing pharmaceutical compositions having an increased active substance dissolution rate, and the compositions obtained |
| 03/11/2002 | CA2356466A1 Pharmaceutical preparations containing soy isoflavone extracts and probiotic micro-organisms |
| 03/07/2002 | WO2002019213A2 Method for treatment of migraine using pde5 inhibitors |
| 03/07/2002 | WO2002018941A2 Screen for glutamate reuptake inhibitors, stimulators, and modulators |
| 03/07/2002 | WO2002018938A1 Method for identifying substances which positively influence inflammatory conditions of chronic inflammatory airway diseases |
| 03/07/2002 | WO2002018909A2 Single riser/single capillary blood viscometer using mass detection or column height detection |
| 03/07/2002 | WO2002018637A2 Diagnosis and treatment of prostate cancer |
| 03/07/2002 | WO2002018632A2 Method for determining the degree of methylation of defined cytosines in genomic dna in the sequence context 5'-cpg-3' |
| 03/07/2002 | WO2002018619A2 Nucleic acid constructs including a novel t-cell active promoter, and pharmaceutical compositions and methods utilizing same for regulating t-cell mediated immune response |
| 03/07/2002 | WO2002018608A2 Methods for enhancing the efficacy of cancer therapy |
| 03/07/2002 | WO2002018593A2 Modulation of fas and fasl expression |
| 03/07/2002 | WO2002018540A2 Pyridine derivatives useful as cd40:cd154 binding interruptor compounds and use thereof to treat immunological complications |
| 03/07/2002 | WO2002018449A1 Nitroderivatives of polysaccharides |
| 03/07/2002 | WO2002018440A1 Anti-angiogenic peptides |
| 03/07/2002 | WO2002018404A2 Nucleoside derivatives for the treatment of hepatitis c |
| 03/07/2002 | WO2002018395A1 Phosphate derivatives as immunoregulatory agents |
| 03/07/2002 | WO2002018390A1 Process for preparation of hydrates of olanzapine and their conversion into crystalline forms of olanzapine |
| 03/07/2002 | WO2002018389A2 Thienopyrimidine |
| 03/07/2002 | WO2002018387A1 2,5-dihydro-pyrazolo[3,4-d]pyrimidin-4-ones with an anticonvulsive action and methods for producing the same |
| 03/07/2002 | WO2002018386A1 2-PYRIDINYL-6,7,8,9-TETRAHYDROPYRIMIDO[1,2-a]PYRIMIDIN-4-ONE AND 7-PYRIDINYL-2,3-DIHYDROIMIDAZO[1,2-a]PYRIMIDIN-5(1H)ONE DERIVATI VES |
| 03/07/2002 | WO2002018385A1 1-[ALKYL], 1-[(HETEROARYL)ALKYL] AND 1-[(ARYL)ALKYL]-7-PYRIDINYL-IMIDAZO[1,2-a]PYRIMIDIN-5(1H)-ONE DERIVATIVES |
| 03/07/2002 | WO2002018384A1 Process for the preparation of vitronectin receptor antagonists |
| 03/07/2002 | WO2002018383A2 Aza heterocyclic derivatives and their therapeutic use |
| 03/07/2002 | WO2002018382A1 Pyrazolopyridine compound and pharmaceutical use thereof |
| 03/07/2002 | WO2002018381A1 6,7-dihydro-pyrrolo[3,4-b]pyridin-5-ones with an anticonvulsive action and methods for producing the same |
| 03/07/2002 | WO2002018380A1 7-oxo pyridopyrimidines as inhibitors of a cellular proliferation |
| 03/07/2002 | WO2002018379A2 7-oxo pyridopyrimidines |
| 03/07/2002 | WO2002018377A1 Compounds containing a bicyclic ring system useful as alpha v beta 3 antagonists |
| 03/07/2002 | WO2002018374A1 Substituted pyrimidines as selective cyclooxygenase-2 inhibitors |
| 03/07/2002 | WO2002018373A1 Quinazoline derivatives, medicaments containing these compounds, their use, and methods for the production thereof |
| 03/07/2002 | WO2002018371A1 Nucleoside metabolism inhibitors |
| 03/07/2002 | WO2002018370A1 Bicyclic heterocycles, medicaments containing these compounds, their use, and methods for the production thereof |
| 03/07/2002 | WO2002018369A2 Peptidomimetic protease inhibitors |
| 03/07/2002 | WO2002018368A1 Tricyclic antitumor compounds being farnesyl protein transferase inhibitors |
| 03/07/2002 | WO2002018367A1 Tetrahydrobenzindole derivatives capable of binding to 5-ht7 receptor and metabolically stable |
| 03/07/2002 | WO2002018361A2 Compounds having activity as inhibitors of cytochrome p450rai |
| 03/07/2002 | WO2002018358A1 N-(3,5-dichloro-2-methoxyphenyl)-4-methoxy-3-piperazin-1-yl-benzenesulfonamide |
| 03/07/2002 | WO2002018355A1 Oxazolyl-aryloxyacetic acid derivatives and their use as ppar agonists |
| 03/07/2002 | WO2002018353A2 Oxazolidinone chemotherapeutic agents |
| 03/07/2002 | WO2002018348A2 Quinazoline derivatives as alpha-1 adrenergic antagonists |
| 03/07/2002 | WO2002018346A1 Pyrazole derivatives and their use as protein kinase inhibitors |
| 03/07/2002 | WO2002018345A1 Quinoline antibacterial compounds and methods of use thereof |
| 03/07/2002 | WO2002018344A1 Novel ester or amide derivatives |
| 03/07/2002 | WO2002018343A1 Method for synthesizing flosequinan from 4-fluoroanthranilic acid |
| 03/07/2002 | WO2002018340A1 GEM-SUBSTITUTED α v β 3 INTEGRIN ANTAGONISTS |
| 03/07/2002 | WO2002018333A1 Phenoxybenzylamine derivatives as selective serotonin re-uptake inhibitors |
| 03/07/2002 | WO2002018330A1 5-asa derivatives having anti-inflammatory and antibiotic activity and methods of treating diseases therewith |
| 03/07/2002 | WO2002018327A2 Guanidinobenzamides as mc4-r agonists |
| 03/07/2002 | WO2002018324A2 Immunoregulatory compounds, derivatives thereof and their use |
| 03/07/2002 | WO2002018320A2 INHIBITORS OF α4 MEDIATED CELL ADHESION |
| 03/07/2002 | WO2002018310A1 Method of obtaining a hydroxytyrosol-rich composition from vegetation water |
| 03/07/2002 | WO2002017971A1 Slow release pharmaceutical preparation and method of administering same |
| 03/07/2002 | WO2002017967A1 Method of increasing testosterone and related steroid concentrations in women |
| 03/07/2002 | WO2002017966A1 Antacid chewing gum products coated with high viscosity materials |
| 03/07/2002 | WO2002017963A2 Modulators of intermediate conductance calcium-activated potassium (ikca) channel activity for treating sexual dysfunction |
| 03/07/2002 | WO2002017958A1 Agent for influencing angiogenesis |
| 03/07/2002 | WO2002017954A1 Antiparkinsonism drugs |
| 03/07/2002 | WO2002017952A2 Inhibition of mitogen-activated protein kinase (mapk) pathway: a selective therapeutic strategy against melanoma |
| 03/07/2002 | WO2002017949A2 Novel functions for dp214 |
| 03/07/2002 | WO2002017945A1 Efficient method for producing compositions enriched in anthocyanins |
| 03/07/2002 | WO2002017944A1 Use of a composition comprising an extract of pollen for the treatment of hormonally-related disorders |
| 03/07/2002 | WO2002017943A1 Use of a composition comprising an extract of pollen for the treatment of disease-related weight gain |
| 03/07/2002 | WO2002017942A1 Use of a composition comprising an extract of pollen for the treatment of irritability |
| 03/07/2002 | WO2002017941A1 Use of a composition comprising an extract of pollen for the treatment of edema |
| 03/07/2002 | WO2002017940A1 Use of a composition comprising an extract of pollen for the treatment of dysphoria |
| 03/07/2002 | WO2002017939A1 A composition comprising pharmaceutical/nutraceutical agent and a bio-enhancer obtained from glycyrrhiza glabra |
| 03/07/2002 | WO2002017933A1 Trace elements |
| 03/07/2002 | WO2002017932A1 Oct preparations |
| 03/07/2002 | WO2002017931A1 Use of tripterygium wilfordii hook.f's extracts for preparation of medicaments for preventing and treating nervous system disorde rs |
| 03/07/2002 | WO2002017930A2 Glucocorticoid blocking agents for increasing blood-brain barrier permeability |